TVM Capital Life Science
Philipp Lechner has a background in finance and economics, with experience in investment banking and venture capital. Philipp has worked at various companies such as TVM Capital Life Science, Die Welt, Societe Generale Corporate and Investment Banking, BNP Paribas, and IKB Deutsche Industriebank AG. Philipp's roles have involved market research, analysis, valuation, and credit applications. Philipp also has experience in strategic controlling for the wealth management unit at LBBW. Philipp holds a Master's degree in International Finance and Economics and a Bachelor's degree in International Financial Management. Philipp has also participated in the CFA Institute Challenge.
This person is not in any offices
TVM Capital Life Science
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.